Search Results - "methotrexate"

Refine Results
  1. 1

    Genetic polymorphisms as predictors of methotrexate toxicity: literature review by G. A. Radzhabova, T. T. Valiev, Yu. E. Ryabukhina, M. I. Savelyeva, Sh. P. Abdullaev, O. D. Gurieva, P. A. Zeynalova

    Published 2024-04-01

    Background. A significant advancement in the treatment of high-grade aggressive non-Hodgkin’s lymphomas and acute lymphoblastic leukemia is the inclusion of high-dose (1000–5000 mg/m2) methotrexate in the treatment protocol. This approach has significantly increased the long-term survival rate, but...

    Full description

    Subjects: Get full text
    Article
  2. 2

    Efficacy and safety of rapid dose escalation of methotrexate in rheumatoid arthritis. Results of the multicenter “METEOR” study by V. N. Amirjanova, E. Yu. Polishchuk, O. N. Anoshenkova, I. B. Vinogradova, E. V. Zonova, L. V. Ivanova, R. R. Samigullina, T. S. Salnikova, E. L. Shakhramanova, E. I. Shmidt, S. P. Yakupova, A. M. Lila, E. L. Nasonov

    Published 2025-03-01

    The aim of the study – to analyze the effectiveness and tolerability of subcutaneous methotrexate (sc MTX) (Metorthrit; S.C. Rompharm Company S.R.L) in patients with rheumatoid arthritis (RA) with high disease activity and rapid dose escalation, to assess their quality of life (QoL) in real clinical...

    Full description

    Subjects: Get full text
    Article
  3. 3

    Use of disease-modifying anti-rheumatic drugs in the therapy of osteoarthritis by S. G. Anikin, L. I. Alekseeva, A. M. Lila

    Published 2019-05-01

    Osteoarthritis (OA) is a heterogeneous disease with varying degrees of inflammatory responses, structural changes, functional insufficiency, and disease progression as a whole. Some OA phenotypes are characterized by a high local inflammatory response, persistent pain, persistent synovitis, and seve...

    Full description

    Subjects: Get full text
    Article
  4. 4

    Methotrexate in a psoriatic arthritis patient by K. V. Aleksanyan, E. S. Zholobova, S. N. Chebysheva, A. V. Meleshkina, M. N. Nikolaeva

    Published 2016-09-01

    The case report a psoriatic arthritis patient (disfiguring form, high laboratory values, changes of the skin and nails) treated with methotrexate. The drug demonstrated high efficacy resulting in stable sustained remission of articular syndrome, documented both by clinical and laboratory parameters, de...

    Full description

    Subjects: Get full text
    Article
  5. 5

    Simultaneous Determination of Unbound Plasma Concentration of Methotrexate and 7-Hydroxymethotrexate in Children Patients Receiving High-Dose Methotrexate Therapy by Dong WC, Gao SS, Shi B, Li HR, Jiang Y, Guo JL, Zhang ZQ, Zhang YZ

    Published 2025-05-01

    Wei-Chong Dong,1,2 Shuai-Shuai Gao,1 Bo Shi,3 Hao-Ran Li,1 Ye Jiang,4,5 Jia-Liang Guo,3 Zhi-Qing Zhang,1 Ying-Ze Zhang2,3 1Department of Pharmacy, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, 050051, People’s Republic of China; 2The School of Medicine, Nankai Univer...

    Full description

    Subjects: “…Methotrexate…”
    Get full text
    Article
  6. 6

    PENTOXIFILLIN INTHETREATMENTOF RHEUMATOID ARTHRITIS by I R Kolosova, G. V. Loukina, Ya. A. Sigidin, A. I. Speransky

    Published 2001-10-01

    Objective. Assessment of the efficacy and tolerability of Pentoxifilline (PF) as compared with Methotrexate [ MT> and combination of MT+PF in patients with rheumatoid arthritis (RA). Material and methods. Controlled study of the efficacy and tolerability of MT, PF and their combination was do...

    Full description

    Subjects: Get full text
    Article
  7. 7

    METHOTREXATE IN THE TREATMENT OF COXITIS IN EARLY SPONDYLOARTHRITIS: ARE THERE PROSPECTS? by T. V. Dubinina, A. B. Demina, Sh. F. Erdes

    Published 2015-09-01

    Hip joint injury, coxitis, is a characteristic manifestation of ankylosing spondylitis. Coxitis therapy has not been elaborated so far. There are few publications on the efficacy of tumor necrosis factor-α inhibitors. Alternative pharmacotherapies, including use of methotrexate, have not fully been...

    Full description

    Subjects: Get full text
    Article
  8. 8

    POSSIBILITY OF ANTIDESTRUCTIVE EFFECT OF LOW DOSES OF CORTICOSTEROIDS IN RHEUMATOID ARTHRITIS: PRELIMINARY INFORMATION by N A Grunina, E A Vinogradova, N N Nadirova

    Published 2000-02-01

    Summary Aim of study: Control ofpossible antidestructive effect of low doses of corticosteroids (CS) on the background of basic therapy of rheumatoid arthritis (RA) by methotrexate (MT). Materials and methods: Preliminary results from 38 out of planned 80 patients (all females) aged 23-68 and diseas...

    Full description

    Subjects: Get full text
    Article
  9. 9

    THE EXPERIENCE OF REMICADE USAGE IN THE TREATMENT OF RHEUMATOID ARTHRITIS PTS by N F Soroka, I. P. Grigorchuk, I N Alikevich

    Published 2002-06-01

    A bstract. Objective. To study the efficacy and tolerability of Remicade in RA Material and methods. 20 reliable RA pts compatible to criteria for inclusion into the study and without exclusion criteria. 18 women and 2 men aged 30-60 and older wilh disease term from 3 lo 10 years and longer. In 14 p...

    Full description

    Subjects: “…methotrexate…”
    Get full text
    Article
  10. 10

    A CLINICAL EXPERIENCE OF METHOTREXATE USE IN TREATMENT OF PATIENT WITH JUVENILE OLIGOARTHRITIS by K.B. Isaeva, E.I. Alexeeva, R.V. Denisova, T.V. Sleptsova, Т.М. Bzarova

    Published 2011-11-01

    This article presents clinical case of early manifestation of juvenile oligoarthritis with rapid contracture and destructive joint changes formation. Methotrexate was administered IM 15 mg/m2 once a week. After 3 months of treatment — acute inflammatory changes in the joint were relieved as well as...

    Full description

    Subjects: Get full text
    Article
  11. 11

    Use of methotrexate in the treatment of psoriasis and psoriatic arthritis by Tatiana Viktorovna Korotaeva, E L Nasonov, V A Molochkov

    Published 2013-06-01

    Objective: To analyze the results of using methotrexate (MT) in the treatment of psoriasis and psoriatic arthritis (PsA). Results. The mechanism of action of MT, the historical aspects of its use in the treatment of psoriasis and PsA, and the data of clinical trials of the efficacy and safety of the...

    Full description

    Subjects: Get full text
    Article
  12. 12

    About molecular characteristic peripheral blood lymphocytes in pts with rheumatoid arthritis by I. R. Kolosova, E R Polosuhina, A Y Barislmikov, G V Lukina, J A Sigidin

    Published 2003-06-01

    Objective. To study lymphocytes phenotype in rheumatoid arthritis (RA) and its changes during methotrexate (MT) therapy. Methods. 24 RA pts with high clinical and laboratory activity of the disease and 18 healthy donors (control group) were included. All patients received MT 7,5-15 mg/week. They wer...

    Full description

    Subjects: Get full text
    Article
  13. 13

    USE OF SUBCUTANEOUS METHOTREXATE FOR THE TREATMENT OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: THE REMARCA TRIAL by D. E. Karateev, E. L. Luchikhina, N. V. Demidova, G. S. Gridneva, G. V. Lukina, M. A. Kanonirova, Yu. V. Muravyev, K. A. Kasumova, E. N. Aleksandrova, A. A. Novikov, A. S. Avdeeva, E. L. Nasonov

    Published 2016-07-01

    The early administration of methotrexate (MTX) and the use of its high (by the rheumatology practice standards) doses contribute to the enhanced efficiency of therapy and the reduced severity of rheumatoid arthritis (RA). One of the important merits of MTX in the treatment of RA is the possibility o...

    Full description

    Subjects: Get full text
    Article
  14. 14

    Successful Management of Cervical Ectopic Pregnancy with Methotrexate in a Nulliparous Woman: A Case Report by Franciszek Ługowski, Aleksandra Urban, Joanna Kacperczyk-Bartnik, Ewa Janowska, Jacek Sieńko

    Published 2025-06-01

    <b>Background and Clinical Significance:</b> Implantation of an embryo in the cervical canal is the rarest location of ectopic pregnancy, as it occurs between 1 in 1000 and 1 in 18,000 pregnancies. Dilation and curettage in previous pregnancies have been identified as risk factors in mos...

    Full description

    Subjects: Get full text
    Article
  15. 15

    FOLLOW-UP OF METHOTREXATE EFFECTIVENESS IN A PATIENT WITH JUVENILE POLYARTHRITIS by L. A. Balykova, O. M. Soldatov, N. V. Shchekina, A. V. Krasnopol'skaya, A. N. Os'kina

    Published 2014-07-01

    The article presents a short review of the current notion of the leading role methotrexate in treatment of most clinical variants ofjuvenile idiopathic arthritis. The authors demonstrate that methotrexate is a “gold standard” of antirheumatic therapy and the key disease-modifying drug of pediatric r...

    Full description

    Subjects: Get full text
    Article
  16. 16

    Methotrexate in the treatment of rheumatic disease by Marina Zinovyevna Kanevskaya, S V Gurskaya

    Published 2013-12-01

    The paper reviews the literature on the use of methotrexate (MT) in rheumatoid arthritis (RA) and other rheumatic diseases. The efficacy and tolerability of MT are evaluated. The findings permit its consideration as the gold standard treatment for RA. The main adverse reactions of MT, which are give...

    Full description

    Subjects: Get full text
    Article
  17. 17

    Experience of Two-Year Observation of а Patient with Dercum Disease During Methotrexate Therapy by S. N. Marshala, M. D. Iarovoi, I. V. Semeniakin, E. V. Reznik

    Published 2025-01-01

    Dercum disease, also known as painful lipomatosis, neurolipomatosis, Ander’s syndrome, is a rare illness. The main clinical manifestation of this disease is the presence of painful formations of subcutaneous tissue, localized in various parts of the body: on the limbs, trunk, buttocks. Possible etio...

    Full description

    Subjects: Get full text
    Article
  18. 18

    NEW RECOMMENDATIONS FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS (EULAR, 2013): THE ROLE OF METHOTREXATE by Evgeniy L Nasonov, D E Karateev, N V Chichasova

    Published 2014-03-01

    In our previous publication, we reported the main provisions of the new EULAR recommendations (2013) and discussed some debating points of RA pharmacotherapy that require further research. The purpose of this article is to review the present-day knowledge concerning the use of methotrexate (MT), sin...

    Full description

    Subjects: Get full text
    Article
  19. 19

    Efficacy and tolerability of methotrexate at a dose of 15 mg/week and 10 mg/week in patients with pulmonary sarcoidosis by V.K. Gavrysyuk, I.O. Merenkova, G.L. Gumeniuk, N.V. Pendalchuk, N.D. Morska, N.A. Vlasova

    Published 2021-12-01

    The objective of this study is to conduct a comparative study of the efficacy and safety of methotrexate (MT) at a dose of 10 mg/week and 15 mg/week in patients with pulmonary sarcoidosis having contraindications to GCS therapy. Material and Methods. The study involved 44 patients with stage II pul...

    Full description

    Subjects: Get full text
    Article
  20. 20

    METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS by E. L. Nasonov

    Published 2016-12-01

    As new effective biological agents (BAs) are being widely introduced, in the past decade there have been serious changes in the rheumatoid arthritis (RA) strategy: its basis was the treat-to-target concept. It is emphasized that the basic strategy component is active early aggressive therapy with me...

    Full description

    Subjects: Get full text
    Article